Literature DB >> 3276655

A system for stereotactic radiosurgery with a linear accelerator.

W Lutz1, K R Winston, N Maleki.   

Abstract

A small field irradiation technique to deliver high doses of single fraction photon radiation to small, precisely located volumes (0.5 to 8 cm3) within the brain has been developed. Our method uses a modified Brown-Roberts-Wells (BRS), CT-guided, stereotactic system and a 6 MV linear accelerator equipped with a special collimator (diameters of 12.5 mm to 30.0 mm projected to isocenter) located 23 cm from isocenter. Target localization via planar angiography has been added. Treatment consists of a series of arcing beams using both gantry and couch rotations. During treatment, the patient's head is immobilized independently of the radiotherapy couch and is precisely positioned without reference to room lasers or light field. A precise verification of alignment precedes each treatment. Extensive performance tests have shown that a target, localized by CT, can be irradiated with a positional accuracy of 2.4 mm in any direction with 95% confidence. If angiography is used for localization, the results are better. The dose 1.0 cm outside the target volume is less than 20% of the prescribed dose for a medium sized collimator.

Entities:  

Mesh:

Year:  1988        PMID: 3276655     DOI: 10.1016/0360-3016(88)90446-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  115 in total

1.  Quantifying the gantry sag on linear accelerators and introducing an MLC-based compensation strategy.

Authors:  Weiliang Du; Song Gao; Xiaochun Wang; Rajat J Kudchadker
Journal:  Med Phys       Date:  2012-04       Impact factor: 4.071

Review 2.  Linac radiosurgery as a tool in neurosurgery.

Authors:  R Deinsberger; J Tidstrand
Journal:  Neurosurg Rev       Date:  2005-02-22       Impact factor: 3.042

3.  Stereotactic external beam irradiation system.

Authors:  P P Kumar; A A Patil
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

4.  Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.

Authors:  Matthew M Gestaut; Nitika Thawani; Sangroh Kim; Veera R Gutti; Sameer Jhavar; Niloyjyoti Deb; Andrew Morrow; Russell A Ward; Jason H Huang; Mehul Patel
Journal:  J Neurooncol       Date:  2017-04-13       Impact factor: 4.130

Review 5.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

6.  Characterization of image quality and image-guidance performance of a preclinical microirradiator.

Authors:  R Clarkson; P E Lindsay; S Ansell; G Wilson; S Jelveh; R P Hill; D A Jaffray
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

7.  Robotic real-time translational and rotational head motion correction during frameless stereotactic radiosurgery.

Authors:  Xinmin Liu; Andrew H Belcher; Zachary Grelewicz; Rodney D Wiersma
Journal:  Med Phys       Date:  2015-06       Impact factor: 4.071

8.  An isocenter detection and verification device for use in proton therapy.

Authors:  H Fuse; T Sakae; T Terunuma; M Sato; S Aoki
Journal:  Rev Sci Instrum       Date:  2012-12       Impact factor: 1.523

9.  Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.

Authors:  Vitaly E Siomin; Michael A Vogelbaum; Andrew A Kanner; Shih-Yuan Lee; John H Suh; Gene H Barnett
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases.

Authors:  Roshan S Prabhu; Anees Dhabaan; William A Hall; Tomi Ogunleye; Ian Crocker; Walter J Curran; Hui-Kuo G Shu
Journal:  J Neurooncol       Date:  2013-02-26       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.